Search clinical trials for: LIK066
Total 14 results
-
CSL BehringCompletedPrimary Immunodeficiency (PID)Poland, Germany, France, Romania, Spain, Sweden, Switzerland, United Kingdom
-
Novartis PharmaceuticalsCompleted
-
Novartis PharmaceuticalsCompletedRenal ImpairmentUnited States
-
Novartis PharmaceuticalsCompletedType 2 Diabetes MellitusUnited States
-
Novartis PharmaceuticalsCompletedElevated Body Mass IndexUnited States
-
Novartis PharmaceuticalsCompletedPolycystic Ovary SyndromeGermany, United States
-
Novartis PharmaceuticalsCompletedType 2 Diabetes Mellitus (T2DM)United States
-
Novartis PharmaceuticalsCompletedObesity | OverweightAustria, United Kingdom, United States, Slovakia, Hungary, Czechia, Canada
-
Novartis PharmaceuticalsTerminatedDiabetes Mellitus and Heart FailureUnited States, Belgium, Austria, Croatia, Czechia, Netherlands, Canada, Korea, Republic of, Taiwan, Hungary, United Kingdom, Italy, Bulgaria, Germany, Argentina, Ireland, Norway, Spain, Denmark, Singapore, South Africa, Mexico, Poland, Puerto Rico
-
Novartis PharmaceuticalsTerminatedNon Alcoholic Steatohepatitis (NASH)United States, South Africa, Spain, Germany, Italy, Taiwan, Canada, Korea, Republic of, Singapore, Bulgaria, Estonia, Mexico, Japan, Denmark, United Kingdom, Colombia, Brazil, Belgium, Russian Federation, Puerto Rico, Chile, Argen... and more
-
Novartis PharmaceuticalsCompletedObese Patients With Non-alcoholic Steatohepatitis (NASH)Netherlands, Taiwan, Thailand, United States, Israel, Argentina, Russian Federation, Canada
-
Göteborg UniversityKarolinska Institutet; Umeå UniversityRecruitingUnilateral Primary Aldosteronism, Mineralocorticoid Antagonists Versus Surgical Treatment (UPA-MEST)Primary Hyperaldosteronism Due to Adrenal AdenomaSweden
-
Novartis PharmaceuticalsWithdrawn
-
Novartis PharmaceuticalsCompleted